News

A new method for early melanoma detection, using tumour-specific antibody profiling, was presented at the EADV Congress 2024.

New research presented at EADV 2024 highlights semaglutide’s potential in reducing flare-ups and improving quality of life for hidradenitis suppurativa patients.

Neurologic events following TAVR are linked to worse survival outcomes. Research highlights that strokes pose the greatest mortality risk.

A study has revealed an increased risk of venous thromboembolism in individuals with sickle cell trait compared to those without the trait.

AN AI-BASED model can effectively predict all-cause mortality by identifying incidental extrapulmonary findings on chest CT scans according to a recent study.

This study suggests that contrast-enhanced mammography-guided biopsy is not a suitable substitute for MRI-guided biopsy in evaluating suspicious breast MRI findings

A recent study explores serum anti-PD-1 autoantibodies as a potential biomarker for predicting survival outcomes in patients with advanced hepatocellular carcinoma

This study highlights gender-based differences in melanoma incidence across body sites from 1982–2018 in Australia, the US, and Scotland.